Compugen Ltd (CGEN.OQ)
CGEN.OQ on NASDAQ Stock Exchange Global Market
3.64USD
19 Oct 2018
3.64USD
19 Oct 2018
Change (% chg)
$-0.16 (-4.21%)
$-0.16 (-4.21%)
Prev Close
$3.80
$3.80
Open
$3.79
$3.79
Day's High
$3.79
$3.79
Day's Low
$3.63
$3.63
Volume
37,559
37,559
Avg. Vol
35,694
35,694
52-wk High
$5.00
$5.00
52-wk Low
$2.25
$2.25
Select another date:
Thu, Oct 11 2018
Bristol-Myers to invest in Compugen, collaborate in clinical trials
TEL AVIV Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.
Bristol-Myers to invest in Compugen, collaborate in clinical trials
TEL AVIV, Oct 11 Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumours.
Select another date:
- Compugen Ltd. (CGEN) Compugen and Bristol-Myers Squibb Clinical Collaboration and Equity Investment Conference Call (Transcript)
- Week 39 Breakout Forecast: Short-Term Picks To Give You An Edge
- Week 38 Breakout Forecast: Short-Term Picks To Give You An Edge
- Your Daily Scoop: Compugen's Trial Begins, Tezepelumab Designated, Sarepta's Alternatives
- Week 37 Breakout Forecast: Short-Term Picks To Give You An Edge
- Compugen, 'From Code To Cure': Becoming A Clinical-Stage Company